1 / 1

Mortality rate (%)

0.2 -. 30-day mortality rate after a major bleeding event , in 5 phase III trials comparing dabigatran with warfarin. Adjusted OR: 0.66 (95%CI: 0.44-1.00, P=0.051) . 0.1. Mortality rate (%). Warfarin. Dabigatran. 0.0. 0. 5. 10. 15. 20. 25. 30. 35. Time ( days ).

lumina
Télécharger la présentation

Mortality rate (%)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 0.2 - 30-day mortalityrateafter a major bleedingevent, in 5 phase III trials comparing dabigatran with warfarin Adjusted OR: 0.66 (95%CI: 0.44-1.00, P=0.051) 0.1 Mortalityrate (%) Warfarin Dabigatran 0.0 0 5 10 15 20 25 30 35 Time (days) Majeedet al.,Circulation 2013

More Related